Biotech & Medtech
Biotech & Medtech news — Friday 06 November 2026
31 stories from 5 sources, every one in English. Each links to its publisher.
-
Bispecific J＆J Drug Wins Speedy FDA Approval for Treating Head ＆ Neck Cancer
MedCity News
Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The bispecific antibody was initially approved for treating certain lung cancers. The post Bispecific J&J Drug Wins Speedy FDA…
-
STAT+: States sue Trump administration again to delay Medicaid work requirements
STAT News
The Trump administration is facing another lawsuit over its sweeping changes to Medicaid less than a week after a federal judge ruled that implementation of work requirements would cause “irreparable harm.” The complaint from four states…
-
STAT+: MAHA leader Calley Means castigates White House officials as bending to industry
STAT News
WASHINGTON — The Trump administration’s MAHA agenda has been derailed by corporate interests and the influence of money, a recently departed administration official told the podcaster Joe Rogan in a recording released Friday. Calley Means…
-
Two incoming lawmakers plan to defend health equity from Trump administration cuts
STAT News
Amid a sweep of Democratic victories in Tuesday’s midterms, some online commentators jokingly declared “ Woke is back .” There was little congressional pushback over the past two years as the Trump administration terminated hundreds of…
-
Experian Health Survey: Providers Struggle Amid Increasing Claim Denials
MedCity News
A new Experian Health survey finds that healthcare providers’ efforts to prevent claims denials are falling short, with many reporting an increase in denials over last year and increasingly complex payer requirements. The post Experian…
-
STAT+: Democrats’ midterm landslide spells relief for hospitals
STAT News
The political environment is about to get friendlier for hospitals. With Democrats gaining control of the House and Senate , hospitals will not have to worry about Republican-led efforts to cut Medicaid payments further. In fact, Democrats…
-
Democrats’ midterm victory, and a questionable fertility procedure
STAT News
How will the midterm results affect drug pricing policy? What is the fate of the Food and Drug Administration? And why are women traveling to fertility clinics abroad? On this week’s episode of “The Readout LOUD,” STAT’s biotech podcast…
-
Novartis reveals cancer cases possibly linked to gene therapy Zolgensma
BioPharma Dive
The FDA is now investigating the risk of malignancy associated with Zolgensma and is “evaluating whether regulatory action is appropriate.”
-
STAT+: Up and down the ladder: The latest comings and goings
STAT News
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them . Don’t be shy…
-
STAT+: New tumor cases show common gene therapy tool can come with risk
STAT News
For two decades, researchers debated whether adeno-associated viruses, the small viruses used to deliver new genes into thousands of patients, could in certain cases drive tumors. That debate is over. A series of cases this year has…
-
STAT+: Amgen’s Repatha linked to fewer heart attacks
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Pithy intro text about the biopharma milieu. Novartis cites more tumor reports after Zolgensma Novartis has…
-
New evidence for ancient cannabis use
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Congratulations on making it to the end of the week. This is Jonathan Wosen, STAT’s West Coast Biotech & Life Sciences…
-
The Big Challenge for AI in Healthcare Comes After Approval
MedCity News
Typically, software placed on the market will undergo changes and updates after its initial release. In the case of healthcare AI, changes can occur, often unexpectedly, even when the developers have not updated the model. The post The Big…
-
STAT+: Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more
STAT News
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape, although we do plan to escort Mrs…
-
Why Physician Leadership Is More Important Than Ever
MedCity News
One voice needs to be increasingly present in the rooms where healthcare’s future is being decided: the physician’s. The post Why Physician Leadership Is More Important Than Ever appeared first on MedCity News .
-
Myths of Customer Discovery
MedCity News
Customer discovery is a well accepted idea in any innovation process. At the core of it, it means talking to potential customers about an invention. In reality, it is a more evolved process, and often less understood than it first appears…
-
Lilly, Hims reach GLP-1 deal; Alnylam sales chief to step down
BioPharma Dive
The deal is part of a course change for Hims, which had previously sold knockoff GLP-1 drugs. Elsewhere, a medicine Servier recently acquired failed a key trial and Ultragenyx announced staff cuts.
-
Debunked Episode 31: CVS Health Restructure, AI ROI Report Findings, FTC Warning Letters
MedCity News
In the latest episode of the Debunked podcast, MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, talked about a new report by Bessemer Venture Partners assessing AI ROI, their…
-
This week in charts: 3 drug launches Wall Street is watching
BioPharma Dive
The latest installment in BioPharma Dive’s visualization-focused series features a look at investors’ response to a trio of medicines highlighted in quarterly earnings this week.
-
STAT+: After Medicare punts RPM overhaul to 2029, advocates see window to fight back
STAT News
Medicare regulators this week pushed forward with a controversial plan to ban hospitals and other providers from using third parties to deliver remote patient monitoring services, despite overwhelming opposition from health tech companies…
-
Opinion: AI depends on medical records that don’t always tell the full truth about women
STAT News
In September, the Gallup-Pivotal Women’s Health Survey reported that 34% of U.S. women strongly or somewhat agreed that a health care provider minimized or dismissed their symptoms in the past five years. Thirty-three percent reported…
-
Most people haven’t heard of kratom. What is it, and who’s using it?
STAT News
Over the last few years, the kratom plant and supplements made from it have garnered increasing attention from public health leaders. This broad category of products, which largely skirts any regulation, has seen major surges in potency…
-
Opinion: What it’s like to live with cognitively unimpaired Alzheimer’s disease
STAT News
What is it like to have asymptomatic Alzheimer’s disease? The answer’s obvious, isn’t it? It is like nothing. It’s a silly question, really. How could living without symptoms — the vexing troubles with concentration, word finding…
-
EvoDR: Evolving Dispatching Rules via Large Language Model for Dynamic Flexible Assembly Flow Shop Scheduling
arXiv cs.NE (Neural／Bio)
arXiv:2601.15738v3 Announce Type: replace Abstract: Dynamic flexible assembly flow shop scheduling with multi-product delivery, often with kitting supply and machine-level flexibility, can be found in many applications. It is difficult to…
-
Projection-Free Evolution Strategies for Continuous Prompt Search
arXiv cs.NE (Neural／Bio)
arXiv:2603.13786v2 Announce Type: replace-cross Abstract: Continuous prompt search offers a computationally efficient alternative to conventional parameter tuning in natural language processing tasks. Nevertheless, its practical…
-
From Connection Loss to Collision: Closed-Loop Fault Assessment of a Fly-Connectome SNN
arXiv cs.NE (Neural／Bio)
arXiv:2611.06940v1 Announce Type: cross Abstract: The public release of the complete adult fruit-fly brain connectome enables brain-scale spiking-network studies, motivating closed-loop assessment of connection loss. We test a…
-
When Does Blockwise Additivity Break? Diagnosing and Repairing the Additive Assumption in Distillation-Based Architecture Search
arXiv cs.NE (Neural／Bio)
arXiv:2611.07487v1 Announce Type: cross Abstract: Blockwise distillation methods for architecture search, such as DNA, DONNA, LANA and Puzzle, score each candidate replacement block in isolation and assemble a child network by minimizing…
-
Projection-Free Gradient Tracking Neurodynamic for Distributed Nonnegative Sparse Optimization
arXiv cs.NE (Neural／Bio)
arXiv:2611.07643v1 Announce Type: cross Abstract: This paper proposes a continuous-time, projection-free neurodynamic system based on gradient tracking for distributed nonnegative sparse optimization. Unlike traditional methods, our…
-
How Can Payers Fit Into the Consumer Health Era?
MedCity News
During a panel at MedCity INVEST Digital Health, healthcare experts discussed the role of payers in the new consumer-driven healthcare era. The post How Can Payers Fit Into the Consumer Health Era? appeared first on MedCity News .
-
Do We Have a Choice But to Ensure the Success of VBC? Part 1
MedCity News
In part 1, we delve into how physicians are looking at value-based care. It involves a visit to a local The post Do We Have a Choice But to Ensure the Success of VBC? Part 1 appeared first on MedCity News .
-
Cas12a-based combinatorial knockout screens define the genetic architecture of the DNA damage response
Nature Biotechnology
Nature Biotechnology, Published online: 06 November 2026; doi:10.1038/s41587-026-03339-2 A genetic interaction map of the DNA damage response (DDR) identifies functional relationships among DDR genes and pathways.